Patents for A61P 35 - Antineoplastic agents (221,099)
12/1999
12/29/1999CA2330249A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides
12/29/1999CA2330189A1 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore
12/28/1999US6008385 Centrifugal partition chromatography to purify taxoides such a taxotere using atleast two solvents selected from esters, ethers, aliphatic hydrocarbons and ketones
12/28/1999US6008337 Polynucleotides encoding polypeptides; diagnosis and therpy for acquired immune disease syndrome, gout, addison's/crohn's diseases, adult respiratory distress syndrome, multiple sclerosis; antiarthritic/anticarcinogenic/antidiabetic agents
12/28/1999US6008324 A protein from a plant having a n-glucosidase chain linked by a disulfide bridge to a lectin chain; and interacts with ribosomal rna and inhibits protein sysnthesis; therapy for acquired immune deficiency syndrome; anticarcinogenic agent
12/28/1999US6008243 An enzyme inhibitor for preventing the degradation and remodeling of connective tissues
12/28/1999US6008220 A gelatinase a inhibitor for treating multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer
12/28/1999US6008211 Photoactivatable compounds comprising benzochlorin and furocoumarin
12/28/1999US6008203 Administering a sialylated lactose carbohydrate compound antitumor agent
12/28/1999US6008039 Polynucleotide encoding a novel purinergic P2U receptor
12/28/1999US6008030 A polynucleotide sequences encoding a protein; therapy and diagnosis of infections, respiratory and gastrointestinal disorders; toxic shock syndrome; antiarthritic and anticarcinogenic agents
12/28/1999US6008018 ELL2, a new member of an ELL family of RNA polymerase II elongation factors
12/28/1999US6007988 A library of dna sequences which encode zinc finger polypeptide binding motifs for display on viral particles; the dna sequences having random allocation of amino acids; for producing zinc finger molecules
12/28/1999US6007819 Administering to mammal an antigen and a dipeptide-derivative to induce immunoglobulin g immune response; vaccines
12/28/1999US6007817 Vasopermeability enhancing immunoconjugates
12/28/1999US6007807 Hybrid fusion cell comprising idiotypic antibody-expressing malignant b cell fused to b cell hybridoma expressing an antibody which is internalized on an antigen presenting cell
12/28/1999US6007792 Chelate compounds labeled with technetium-99m, rhenium-186, or rhenium-188; tumor imaging
12/28/1999CA2001715C Carbocyclic nucleosides and nucleotides
12/28/1999CA1340862C Method of producing a human protein and dna-sequence for use when carrying out the method
12/28/1999CA1340861C Cysteine-depleted muteins of biologically active proteins
12/23/1999WO1999066051A2 Nek-related and bub1-related protein kinases
12/23/1999WO1999066048A1 A mutant human hepatitis b viral strain and uses thereof
12/23/1999WO1999066047A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999WO1999066038A1 Angiostatin-binding protein
12/23/1999WO1999066037A2 Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
12/23/1999WO1999066030A1 Dap-kinase related protein
12/23/1999WO1999065947A2 Monoclonal antibodies directed against the g3bp protein, and uses
12/23/1999WO1999065942A1 Cyclic somatostatin analogs
12/23/1999WO1999065940A1 Anti-angiogenic proteins and methods of use thereof
12/23/1999WO1999065939A1 INTERACTION OF p27(KIP1) WITH FKBP-12
12/23/1999WO1999065924A2 Preparation and use of superior vaccines
12/23/1999WO1999065922A2 Prenyl transferase inhibitors
12/23/1999WO1999065917A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors
12/23/1999WO1999065914A1 Artemisinin derivatives, method for the preparation thereof and pharmaceutical compositions containing the same
12/23/1999WO1999065910A1 Fused azepinone cyclin dependent kinase inhibitors
12/23/1999WO1999065909A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/23/1999WO1999065908A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/23/1999WO1999065898A1 Imidazolyl derivatives
12/23/1999WO1999065897A1 Inhibitors of glycogen synthase kinase 3
12/23/1999WO1999065894A1 Macrocyclic analogs and methods of their use and preparation
12/23/1999WO1999065893A1 Novel benzopyran or thiobenzopyran derivatives
12/23/1999WO1999065887A1 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
12/23/1999WO1999065884A1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
12/23/1999WO1999065880A1 Aryl alkanoylpyridazines
12/23/1999WO1999065872A1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
12/23/1999WO1999065867A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999WO1999065866A1 Anthracene derivatives as anti-cancer agents
12/23/1999WO1999065532A1 Method and device for delivery of therapeutic agents in conjuction with isotope seed placement
12/23/1999WO1999065523A1 Immunotherapeutic composition and method for the treatment of prostate cancer
12/23/1999WO1999065522A1 Hla binding peptides and their uses
12/23/1999WO1999065521A1 Methods and materials for the treatment of prostatic carcinoma
12/23/1999WO1999065517A2 Therapeutic compositions that produce an immune response by altering the antigen
12/23/1999WO1999065515A2 Combination of radiotherapy and anti-angiogenic factors
12/23/1999WO1999065508A1 Conformationally constrained backbone cyclized somatostatin analogs
12/23/1999WO1999065499A1 Cyclophosphamide coated tablets
12/23/1999WO1999065495A1 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
12/23/1999WO1999065493A1 Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects
12/23/1999WO1999065481A1 Liposomal formulations of busulphan
12/23/1999WO1999065478A1 Therapeutic compositions and methods of use
12/23/1999WO1999065466A1 Temperature-sensitive liposomal formulation
12/23/1999WO1999065449A2 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
12/23/1999WO1999065307A1 Methods and compositions for treatment of aids-associated kaposi's sarcoma
12/23/1999WO1999053960A3 Enhancing immune responses to genetic immunization by using a chemokine
12/23/1999WO1999051741A3 Lyst protein complexes and lyst interacting proteins
12/23/1999WO1999049881A3 Application of hsp70 proteins
12/23/1999WO1999045098A3 Delivery or proteins into eukaryotic cells with recombinant yersinia
12/23/1999WO1999033869A3 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
12/23/1999WO1999033859A3 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
12/23/1999WO1999028748A3 Hla-e binding
12/23/1999DE19852804C1 Pharmaceutical composition for manipulating angiogenesis
12/23/1999DE19826841A1 Arylalkanoylpyridazine Arylalkanoylpyridazine
12/23/1999DE19825591A1 Pharmazeutische Kombinationen zum Ausgleich eines Testosteron-Defizits beim Mann mit gleichzeitigem Schutz der Prostata Pharmaceutical combinations to offset a deficit testosterone in men with prostate while protecting the
12/23/1999DE19812375C1 Für Tumorsuppressorproteine codierende Nucleinsäure, Tumorsuppressorproteine, Verfahren zu deren Herstellung, Antikörper gegen Tumorsuppressorproteine und Verwendung dieser Gegenstände For nucleic acid coding for tumor suppressor proteins, tumor suppressor proteins, processes for their preparation, to antibodies against tumor suppressor proteins and use of these articles
12/23/1999CA2755266A1 Intermediates for preparing macrocyclic analogs
12/23/1999CA2342990A1 Artemisinin derivatives, method for the preparation thereof and pharmaceutical compositions containing the same
12/23/1999CA2337603A1 Prenyl transferase inhibitors
12/23/1999CA2335724A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors
12/23/1999CA2335452A1 Preparation and use of superior vaccines
12/23/1999CA2335435A1 Imidazolyl derivatives
12/23/1999CA2335337A1 Methods and materials for the treatment of prostatic carcinoma
12/23/1999CA2335294A1 Inhibitors of transcription factor nf-.kappa.b
12/23/1999CA2335293A1 Inhibitors of transcription factor nf-.kappa.b
12/23/1999CA2335184A1 Cyclic somatostatin analogs
12/23/1999CA2335038A1 Combination of radiotherapy and anti-angiogenic factors
12/23/1999CA2334797A1 Anthracene derivatives as anti-cancer agents
12/23/1999CA2334634A1 Novel benzopyran or thiobenzopyran derivatives
12/23/1999CA2334254A1 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
12/23/1999CA2333554A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999CA2333221A1 Therapeutic compositions that produce an immune response by altering the antigen
12/23/1999CA2332325A1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
12/23/1999CA2332173A1 A vaccine-induced hepatitis b viral strain and uses thereof
12/23/1999CA2331889A1 Nek-related and bub1-related protein kinases
12/23/1999CA2331382A1 Interaction of p27(kip1) with fkbp-12
12/23/1999CA2331332A1 Anti-angiogenic proteins and methods of use thereof
12/23/1999CA2331151A1 Monoclonal antibodies directed against the g3bp protein, and uses
12/23/1999CA2330824A1 Hla binding peptides and their uses
12/23/1999CA2330228A1 Angiostatin-binding protein
12/23/1999CA2328504A1 Immunotherapeutic composition and method for the treatment of prostate cancer
12/23/1999CA2301665A1 Methods and compositions for treatment of aids-associated kaposi's sarcoma
12/23/1999CA2300892A1 Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects